focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHRM.L Regulatory News (PHRM)

  • There is currently no data for PHRM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Operations Update

27 Sep 2013 07:00

RNS Number : 0573P
Phorm Corporation Limited
27 September 2013
 

27 September 2013

 

Phorm Corporation Limited ("Phorm" or the "Company")

 

Operations Update

 

Revenue and Key Performance Indicators Show Strong Growth

 

 

Phorm (AIM: PHRM), a leading internet personalization technology company, announces today that it is seeing strong sustained growth in revenue and other key performance indicators.

 

· 3.6 million monthly opted-in users

· 1.2 million active on daily basis, 100% increase from June

· Advertising network and publisher partners provide over 1.2 billion requests per month

· Over 66 million advertising impressions served in August

· Advertising products demonstrating excellent performance

· Increasing evidence of market-leading conversion rates

 

Phorm previously announced on 28 June that it had reached commercial scale in Turkey such that it was delivering advertising campaigns and that revenue generation had commenced. Despite market activity being at seasonal lows, considerable commercial traction has been achieved over recent months and the Company has seen considerable growth in revenues and other Key Performance Indicators including user numbers, advertising requests and advertising impressions served. In addition, Phorm has received very exciting feedback from its customers, with respect to conversion rates, which demonstrates that its platform has the ability to compete effectively in text advertising.

 

Phorm is pleased to announce that the number of daily active users is now 1.2 million, a 100% increase on the number previously announced on 28 June and the rate of growth is increasing. Phorm has now conclusively demonstrated the viability of an opt-in model and is pleased that it continues to lead the market in terms of consumer choice and protection.

 

Phorm has continued to sign and build its publisher network. In June, the Company announced that it was receiving an average of 30 million requests per day, this has now grown to over 40 million requests per day. In August the Company received a total of over 1.2 billion advertising requests.

 

The number of advertising impressions served by the Company is also continuing to grow. In June the Company served 39 million, this has grown by over 70% to 67 million by the end of August. Phorm is able to serve both display and text advertising, which allows advertisers to target advertising at the key-word level without using a search engine.

 

Phorm is also delighted to announce that it has received some excellent feedback from its advertising partners with respect to conversion rates. Conversion is key to ensuring the long-term success of the platform as it is the measure of the proportion of clicks that result in the user action desired by the advertiser; for example to buy a product or fill in an application form. Phorm has demonstrated across a range of sectors and campaigns that its targeted advertising can result in very high conversion rates. In recent campaigns, Phorm has achieved conversion rates of up to 40%.

 

The Company is now focused on building its revenue based on these excellent results and will update the market further in due course.

 

-ends-

 

Contact

 

Phorm Corporation Limited

 

Andy Croxson (analysts & investors) +44 207 297 2067

 

Liberum Capital +44 20 3100 2222 (Nominated Advisor and Joint Broker)

 

Chris Bowman

Richard Bootle

 

Mirabaud Securities LLP +44 20 7321 2508 (Joint Broker)

 

Jason Woollard

Peter Krens

 

About Phorm

 

Phorm is a global personalization technology company that makes content and advertising more relevant to the consumer. Phorm's innovative platform preserves user privacy and delivers a more interesting online experience.

 

Phorm's industry leading technology enables its ISP partners to offer a new type of online advertising platform and a free consumer internet content feature, ensuring more relevant advertisements and personalized content for opted-in users.

 

Phorm's advertising platform revolutionizes current standards of online privacy, fully protecting the identity of consumers. Unlike virtually all other targeted advertising propositions, Phorm's solution is completely opt-in. Only those users consenting to the service are profiled and only ever on an anonymous basis.

 

Phorm's partners include leading Internet Service Providers (ISPs), Publishers, Advertising Networks and Advertisers.

 

Phorm, under a predecessor holding company, was admitted to the AIM market of the London Stock Exchange in 2004.

 

For more information, please visit: www.phorm.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLLFSDAFIRFIV
Date   Source Headline
5th Jan 20107:00 amRNSTransfer of shares
17th Dec 200911:51 amRNSPurchase of Shares and Total Voting Rights
4th Nov 20092:18 pmRNSNotification of major interest in shares
2nd Nov 200912:42 pmRNSResult of AGM
6th Oct 20092:07 pmRNSNotice of AGM
2nd Oct 20097:00 amRNSNotification of major interest in shares
21st Sep 20097:00 amRNSInterim results
14th Sep 20098:57 amRNSNotification of Results
5th Aug 20097:00 amRNSTransfer of Shares
8th Jul 20098:27 amRNSOperational Update
6th Jul 20099:22 amRNSStatement on UK operations
30th Jun 20097:13 amRNSAnnual Accounts
19th Jun 200911:06 amRNSTotal Voting Rights
18th Jun 20097:00 amRNSFinal Results
10th Jun 20097:00 amRNSPlacing to raise ?15 million
3rd Jun 200911:00 amRNSPhorm announces Webwise Discover
21st May 20097:00 amRNSKorean Market Trial
27th Apr 200910:31 amRNSStatement re Apology from "New Media Age" Magazine
14th Apr 20096:23 pmRNSPhorm Statement re EU Commission
9th Apr 20093:57 pmRNSAIM Block Admission
30th Mar 20097:00 amRNSKorean Market Trial
26th Mar 20097:03 amRNSGrant of Options
19th Mar 20091:31 pmRNSGrant of Options
18th Mar 20097:00 amRNSChange of Broker
13th Mar 20095:03 pmRNSShare Issue - Replacement
13th Mar 20092:46 pmRNSShare Issue
11th Mar 20099:49 amRNSAnnouncement of Appointments
4th Mar 20093:18 pmRNSCity Events Wire
17th Dec 20085:52 pmRNSManagement Appointments
15th Dec 20087:00 amRNSBT Trial Update
1st Dec 20087:00 amRNSPhorm Announces Board Changes
5th Nov 20087:46 amRNSDisclosure of Share Sale
22nd Oct 20085:14 pmRNSGrant of options
14th Oct 200810:15 amRNSCancellation of admission of shares
30th Sep 20087:00 amRNSInterim Results
29th Sep 20087:00 amRNSCommencement of BT Trial
22nd Sep 200811:15 amRNSResponse to Statement by BERR
4th Sep 20087:00 amRNSPhorm Update
18th Aug 20087:00 amRNSAppointment of Independent Bo
24th Jun 20087:00 amRNSTransfer of Shares
14th May 20084:45 pmRNSExercise of Options
14th May 200812:55 pmRNSAnnual Report and Accounts
10th Apr 20087:01 amRNSFinal Results
4th Apr 20084:23 pmRNSNotification of Holding
4th Apr 20084:16 pmRNSNotification Of Shareholding
4th Apr 200812:11 pmRNSNotification Of Shareholding
19th Mar 20087:01 amRNSIssue of Equity
13th Mar 200811:32 amRNSResult of Stockholder Meeting
11th Mar 20087:02 amRNSRe Share Price Movement
28th Feb 20085:50 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.